This approach not only prevents the recruitment of granulocytic MDSCs via CXCR2 blockade but also depletes TAMs through CSF1R inhibition, thereby disrupting immune evasion mechanisms within the melanoma microenvironment [282]. This evidence concerns the gene CXCR2 and melanoma.